S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

iRhythm Technologies Stock Forecast, Price & News

-0.50 (-0.51%)
(As of 11/26/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
191,600 shs
Average Volume
596,391 shs
Market Capitalization
$2.88 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive IRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

iRhythm Technologies logo

About iRhythm Technologies

iRhythm Technologies, Inc. engages in the development of monitoring and diagnostic solutions for detection of cardiac arrhythmias. It offers Zio XT, is a wearable patch-based biosensor, continuously records, and stores ECG data from every patient heartbeat for up to 14 consecutive days; and Zio AT, also provides ECG data but also provides physicians with actionable notifications during the wear period. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.


iRhythm Technologies (NASDAQ:IRTC) Trading Down 8.9%
November 5, 2021 |  americanbankingnews.com
iRhythm Technologies (NASDAQ:IRTC) Shares Gap Down to $122.12
November 4, 2021 |  americanbankingnews.com
Why iRhythm Technologies Stock Skyrocketed Today
November 3, 2021 |  finance.yahoo.com
Let's Improvise as iRhythm Technologies Heads into Earnings
November 2, 2021 |  realmoney.thestreet.com
See More Headlines

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$265.17 million
Book Value
$10.05 per share


Net Income
$-43.83 million
Pretax Margin




Free Float
Market Cap
$2.88 billion

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

2.02 out of 5 stars

Medical Sector

585th out of 1,391 stocks

Surgical & Medical Instruments Industry

59th out of 125 stocks

Analyst Opinion: 3.2Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -

iRhythm Technologies (NASDAQ:IRTC) Frequently Asked Questions

Is iRhythm Technologies a buy right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 7 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" iRhythm Technologies stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IRTC, but not buy additional shares or sell existing shares.
View analyst ratings for iRhythm Technologies
or view top-rated stocks.

How has iRhythm Technologies' stock been impacted by Coronavirus?

iRhythm Technologies' stock was trading at $85.54 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, IRTC stock has increased by 14.6% and is now trading at $98.00.
View which stocks have been most impacted by COVID-19

When is iRhythm Technologies' next earnings date?

iRhythm Technologies is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for iRhythm Technologies

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) released its earnings results on Thursday, November, 4th. The company reported ($0.81) earnings per share for the quarter, topping the consensus estimate of ($1.09) by $0.28. The business earned $85.43 million during the quarter, compared to the consensus estimate of $83.65 million. iRhythm Technologies had a negative net margin of 24.55% and a negative trailing twelve-month return on equity of 25.06%. The business's revenue for the quarter was up 18.7% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.17) EPS.
View iRhythm Technologies' earnings history

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies updated its FY 2021 earnings guidance on Thursday, November, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $317 million-$319 million, compared to the consensus revenue estimate of $323.46 million.

What price target have analysts set for IRTC?

10 brokerages have issued 12-month price objectives for iRhythm Technologies' shares. Their forecasts range from $70.00 to $238.00. On average, they anticipate iRhythm Technologies' share price to reach $144.22 in the next twelve months. This suggests a possible upside of 47.2% from the stock's current price.
View analysts' price targets for iRhythm Technologies
or view top-rated stocks among Wall Street analysts.

Who are iRhythm Technologies' key executives?

iRhythm Technologies' management team includes the following people:
  • Quentin S. Blackford, President, Chief Executive Officer & Director
  • Douglas J. Devine, Chief Financial Officer
  • Mark J. Day, Executive Vice President-Research & Development
  • Judith Lenane, Chief Clinical Officer & Executive VP-Products
  • Allan B. Wilsker, EVP-Information Technology & Customer Services

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies CEO Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among iRhythm Technologies' employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Square (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by many different retail and institutional investors. Top institutional investors include Sands Capital Management LLC (11.20%), BlackRock Inc. (7.01%), Mackenzie Financial Corp (6.47%), Credit Suisse AG (3.97%), Wellington Management Group LLP (3.79%) and Vident Investment Advisory LLC (1.96%). Company insiders that own iRhythm Technologies stock include David A Vort, Kevin M King, Mark J Day, Matthew C Garrett, Ralph Snyderman and Raymond W Scott.
View institutional ownership trends for iRhythm Technologies

Which institutional investors are selling iRhythm Technologies stock?

IRTC stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Millennium Management LLC, Assenagon Asset Management S.A., Cubist Systematic Strategies LLC, Renaissance Technologies LLC, Alliancebernstein L.P., Voloridge Investment Management LLC, and Man Group plc.
View insider buying and selling activity for iRhythm Technologies
or view top insider-selling stocks.

Which institutional investors are buying iRhythm Technologies stock?

IRTC stock was acquired by a variety of institutional investors in the last quarter, including Camber Capital Management LP, Vident Investment Advisory LLC, Bank of New York Mellon Corp, Balyasny Asset Management LLC, Eversept Partners LP, Clough Capital Partners L P, Mackenzie Financial Corp, and Polar Asset Management Partners Inc..
View insider buying and selling activity for iRhythm Technologies
or or view top insider-buying stocks.

How do I buy shares of iRhythm Technologies?

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $98.00.

How much money does iRhythm Technologies make?

iRhythm Technologies has a market capitalization of $2.88 billion and generates $265.17 million in revenue each year. The company earns $-43.83 million in net income (profit) each year or ($2.68) on an earnings per share basis.

How many employees does iRhythm Technologies have?

iRhythm Technologies employs 1,157 workers across the globe.

What is iRhythm Technologies' official website?

The official website for iRhythm Technologies is www.irhythmtech.com.

Where are iRhythm Technologies' headquarters?

iRhythm Technologies is headquartered at 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at (415) 632-5700 or via email at [email protected].

This page was last updated on 11/29/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.